QUADRANT EPP AG – Trademark Portfolio
Entity Type: 03
QUADRANT EPP AG holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 17 (Rubber Goods) — 13 filings in this category. The portfolio also extends into Class 7 (Machinery) across 7 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MEDITECH and QUICKSILVER. The owner is based in 5600 LENZBURG.
HARDSTRASSE 5
5600 LENZBURG , CH
Showing of trademarks Trademarks
Trademark Classifications
QUADRANT EPP AG's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Machines and machine tools; motors and engines; machine coupling and transmission components
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Building materials (non-metallic); non-metallic rigid pipes for building
Frequently Asked Questions
How many trademarks does QUADRANT EPP AG have?
QUADRANT EPP AG has 19 U.S. trademarks filed with the USPTO. Of these, 2 registered, 14 cancelled.
What trademark classes does QUADRANT EPP AG file in?
QUADRANT EPP AG files trademarks across 7 Nice Classification classes. The most active classes are Class 17 (Rubber Goods), Class 7 (Machinery), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 17 covers unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica.
What are QUADRANT EPP AG's most well-known trademarks?
QUADRANT EPP AG's registered trademark portfolio includes well-known marks such as MEDITECH and QUICKSILVER. These are among 2 currently registered trademarks in the portfolio.
What is QUADRANT EPP AG's trademark registration success rate?
QUADRANT EPP AG has a 13% trademark registration rate, with 2 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.